Related Experiment Video
Updated: Aug 15, 2025
Quantitative Analysis of Climbing Defects in a Drosophila Model of Neurodegenerative Disorders
Published on: June 13, 2015
A Drosophila model of the neurological symptoms in Mpv17-related diseases
Atsushi Kodani1, Mizuki Yamaguchi1, Ririka Itoh1
1Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-Ku, Kyoto, 606-8585, Japan.
Abstract:
Mutations in the Mpv17 gene are responsible for MPV17-related hepatocerebral mitochondrial DNA depletion syndrome and Charcot-Marie-Tooth (CMT) disease. Although several models including mouse, zebrafish, and cultured human cells, have been developed, the models do not show any neurological defects, which are often observed in patients. Therefore, we knocked down CG11077 (Drosophila Mpv17; dMpv17), an ortholog of human MPV17, in the nervous system in Drosophila melanogaster and investigated the behavioral and cellular phenotypes. The resulting dMpv17 knockdown larvae showed impaired locomotor activity and learning ability consistent with mitochondrial defects suggested by the reductions in mitochondrial DNA and ATP production and the increases in the levels of lactate and reactive oxygen species. Furthermore, an abnormal morphology of the neuromuscular junction, at the presynaptic terminal, was observed in dMpv17 knockdown larvae. These results reproduce well the symptoms of human diseases and partially reproduce the phenotypes of Mpv17-deficient model organisms. Therefore, we suggest that neuron-specific dMpv17 knockdown in Drosophila is a useful model for investigation of MPV17-related hepatocerebral mitochondrial DNA depletion syndrome and CMT caused by Mpv17 dysfunction.
Insights
Neuron-specific knockdown of Drosophila Mpv17 (CG11077) in flies recapitulates key symptoms of MPV17-related mitochondrial DNA depletion syndrome and Charcot-Marie-Tooth disease, including neurological defects.
Area of Science:
- Genetics
- Neuroscience
- Mitochondrial Biology
Background:
- Mutations in the MPV17 gene cause hepatocerebral mitochondrial DNA depletion syndrome and Charcot-Marie-Tooth (CMT) disease.
- Existing MPV17 models lack neurological phenotypes observed in human patients.
Purpose of the Study:
- To develop a novel Drosophila model that replicates neurological defects associated with MPV17 dysfunction.
- To investigate the cellular and behavioral consequences of impaired MPV17 function in the nervous system.
Main Methods:
- Knockdown of CG11077 (Drosophila MPV17; dMpv17) specifically in the nervous system of Drosophila melanogaster.
- Assessment of locomotor activity, learning ability, mitochondrial DNA levels, ATP production, lactate, and reactive oxygen species.
- Analysis of neuromuscular junction morphology.
Main Results:
- dMpv17 knockdown larvae exhibited impaired locomotor activity and learning, indicative of mitochondrial dysfunction.
- Biochemical analyses revealed reduced mitochondrial DNA and ATP, with increased lactate and reactive oxygen species.
- Abnormal presynaptic terminal morphology was observed at the neuromuscular junction.
Conclusions:
- Neuron-specific dMpv17 knockdown in Drosophila serves as a valuable model for studying MPV17-related disorders.
- This model effectively reproduces key neurological and cellular phenotypes of human MPV17-related diseases.
- The findings support the utility of this Drosophila model for investigating MPV17 dysfunction.
